Abstract
1. 1. 35SO 4 administered intraperitoneally was specifically incorporated into a glycopeptide component separated by electrophoresis of the glycosaminoglycan fraction prepared from the uterine epithelia (luminal), as well as the uterine fluid of ovariectomized rats treated with estradiol-17ß, in contrast to the rats without estrogen treatment. 2. 2. The epithelial cells of uteri isolated from estrogen-treated ovariectomized rats incorporated 35SO 4 in vitro into at least two macromolecular components. The larger molecular weight component (sodium dodecyl sulfate polyacrylamide gel electrophoresis and/or gel filtration) labelled with 35S was observed in both the cytosol and particulate fractions, whereas the smaller molecular weight component labelled with 35S was found only in the particulate fraction. 35SO 4 was also incorporated into two macromolecular components in the incubation medium, similarly to the particulate fraction. A 35SO 4-labelled glycopeptide similar to that from the in vivo 35SO 4-labelled uterine epithelia and fluid was obtained only from the epithelial particulate fraction and the incubation medium, and not from the epithelial cytosol fraction. 3. 3. Progesterone, in contrast to estrogen, did not stimulate the sulfated glycoprotein synthesis. Moreover, progesterone administered together with or after estrogen-administration completely arrested the estrogen-dependent synthesis and secretion of the sulfated glycoproteins in the uterine epithelia.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.